1500 companies401–600 / 8 pages
| Ticker | Company | Country | Industry | Market | Revenue | FY |
|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $40.4mn | 2025 |
| KYMR | Kymera Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $39.2mn | 2025 |
| IMCC | IM Cannabis Corp. | IL | Pharmaceuticals & Healthcare | NASDAQ | CAD 54.7mn | 2025 |
| UTMD | UTAH MEDICAL PRODUCTS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $38.5mn | 2025 |
| RVP | RETRACTABLE TECHNOLOGIES INC | US | Pharmaceuticals & Healthcare | NYSE | $38.3mn | 2025 |
| BGM | BGM Group Ltd. | CN | Pharmaceuticals & Healthcare | NASDAQ | $37.9mn | 2025 |
| CTSO | Cytosorbents Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $37.1mn | 2025 |
| CLPT | ClearPoint Neuro, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $37.0mn | 2025 |
| NBTX | Nanobiotix S.A. | FR | Pharmaceuticals & Healthcare | NASDAQ | €32.6mn | 2025 |
| SBFM | Sunshine Biopharma Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $36.3mn | 2025 |
| CCCC | C4 Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $35.9mn | 2025 |
| VRCA | Verrica Pharmaceuticals Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $35.6mn | 2025 |
| XFOR | X4 Pharmaceuticals, Inc | US | Pharmaceuticals & Healthcare | NASDAQ | $35.1mn | 2025 |
| BHST | BIOHARVEST SCIENCES INC. | CA | Pharmaceuticals & Healthcare | NASDAQ | $34.5mn | 2025 |
| DTIL | PRECISION BIOSCIENCES INC | US | Pharmaceuticals & Healthcare | NASDAQ | $34.3mn | 2025 |
| OBIO | Orchestra BioMed Holdings, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $33.5mn | 2025 |
| RCUS | Arcus Biosciences, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $33.0mn | 2025 |
| STXS | Stereotaxis, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $32.4mn | 2025 |
| ECOR | electroCore, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $32.0mn | 2025 |
| CCEL | CRYO CELL INTERNATIONAL INC | US | Pharmaceuticals & Healthcare | NYSE | $31.6mn | 2025 |
| POCI | PRECISION OPTICS CORPORATION, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $31.5mn | 2026 |
| VSTM | Verastem, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $30.9mn | 2025 |
| FHTX | Foghorn Therapeutics Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $30.9mn | 2025 |
| PRE | Prenetics Global Ltd | HK | Pharmaceuticals & Healthcare | NASDAQ | $30.6mn | 2024 |
| SCLX | Scilex Holding Co | US | Pharmaceuticals & Healthcare | NASDAQ | $30.3mn | 2025 |
| AMS | AMERICAN SHARED HOSPITAL SERVICES | US | Pharmaceuticals & Healthcare | NYSE | $28.1mn | 2025 |
| ICCC | IMMUCELL CORP /DE/ | US | Pharmaceuticals & Healthcare | NASDAQ | $27.6mn | 2025 |
| SRTS | Sensus Healthcare, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $27.5mn | 2025 |
| CELU | Celularity Inc | US | Pharmaceuticals & Healthcare | NASDAQ | $26.6mn | 2025 |
| TRDA | Entrada Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $25.4mn | 2025 |
| MGX | Metagenomi Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $25.2mn | 2025 |
| ALMS | ALUMIS INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $24.1mn | 2025 |
| NIVF | NewGenIvf Group Ltd | TH | Pharmaceuticals & Healthcare | NASDAQ | $23.7mn | 2025 |
| 4880 | セルソース | JP | Pharmaceuticals & Healthcare | Standard | ¥4bn | 2025 |
| BDMD | Baird Medical Investment Holdings Ltd | HK | Pharmaceuticals & Healthcare | NASDAQ | $22.5mn | 2025 |
| NAMS | NewAmsterdam Pharma Co N.V. | NL | Pharmaceuticals & Healthcare | NASDAQ | $22.5mn | 2025 |
| DRIO | DarioHealth Corp. | US | Pharmaceuticals & Healthcare | NASDAQ | $22.4mn | 2025 |
| ALEC | Alector, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $21.0mn | 2025 |
| SCYX | SCYNEXIS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $20.6mn | 2025 |
| MDAI | Spectral AI, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $19.6mn | 2025 |
| SNOA | Sonoma Pharmaceuticals, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $19.5mn | 2026 |
| LENZ | LENZ Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $19.1mn | 2025 |
| QTI | QT IMAGING HOLDINGS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $18.9mn | 2025 |
| NEPH | NEPHROS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $18.8mn | 2025 |
| BON | Bon Natural Life Ltd | CN | Pharmaceuticals & Healthcare | NASDAQ | $18.7mn | 2025 |
| PRQR | ProQR Therapeutics N.V. | NL | Pharmaceuticals & Healthcare | NASDAQ | €15.9mn | 2025 |
| 4587 | ペプチドリーム | JP | Pharmaceuticals & Healthcare | Prime | ¥3bn | 2025 |
| VVOS | Vivos Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $17.4mn | 2025 |
| ZYBT | Zhengye Biotechnology Holding Ltd | CN | Pharmaceuticals & Healthcare | NASDAQ | CN¥116.4mn | 2025 |
| QURE | uniQure N.V. | NL | Pharmaceuticals & Healthcare | NASDAQ | $16.1mn | 2025 |
| PROF | Profound Medical Corp. | CA | Pharmaceuticals & Healthcare | NASDAQ | $16.1mn | 2025 |
| RLAY | Relay Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $15.4mn | 2025 |
| LCTX | Lineage Cell Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $14.6mn | 2025 |
| IRD | Opus Genetics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $14.2mn | 2025 |
| ABUS | Arbutus Biopharma Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $14.1mn | 2025 |
| PYXS | Pyxis Oncology, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $13.9mn | 2025 |
| HYPR | Hyperfine, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $13.6mn | 2025 |
| CV | CapsoVision, Inc | US | Pharmaceuticals & Healthcare | NASDAQ | $13.6mn | 2025 |
| PTN | PALATIN TECHNOLOGIES INC | US | Pharmaceuticals & Healthcare | NASDAQ | $13.2mn | 2026 |
| TNXP | Tonix Pharmaceuticals Holding Corp. | US | Pharmaceuticals & Healthcare | NASDAQ | $13.1mn | 2025 |
| NNOX | Nano-X Imaging Ltd. | IL | Pharmaceuticals & Healthcare | NASDAQ | $13.0mn | 2025 |
| EVMN | Evommune, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $13.0mn | 2025 |
| PLSM | Pulsenmore Ltd. | IL | Pharmaceuticals & Healthcare | NASDAQ | ILS 40.0mn | 2025 |
| SPRO | Spero Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $12.6mn | 2025 |
| ELUT | ELUTIA INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $12.3mn | 2025 |
| PRLD | Prelude Therapeutics Inc | US | Pharmaceuticals & Healthcare | NASDAQ | $12.1mn | 2025 |
| JAGX | Jaguar Health, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $11.5mn | 2025 |
| NXGL | NEXGEL, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $11.4mn | 2025 |
| CRBU | Caribou Biosciences, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $11.2mn | 2025 |
| CBIO | CRESCENT BIOPHARMA, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $10.8mn | 2025 |
| TCRX | TScan Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $10.3mn | 2025 |
| ACOG | Alpha Cognition Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $10.2mn | 2025 |
| JANX | Janux Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $10.0mn | 2025 |
| ZBIO | Zenas BioPharma, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $10.0mn | 2025 |
| WOK | WORK Medical Technology Group LTD | NZ | Pharmaceuticals & Healthcare | NASDAQ | $9.8mn | 2025 |
| TSHA | Taysha Gene Therapies, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $9.8mn | 2025 |
| PGEN | PRECIGEN, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $9.7mn | 2025 |
| PRTA | PROTHENA CORP PUBLIC LTD CO | IE | Pharmaceuticals & Healthcare | NASDAQ | $9.7mn | 2025 |
| CRIS | CURIS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $9.4mn | 2025 |
| BIOA | BioAge Labs, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $9.0mn | 2025 |
| NSPR | InspireMD, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $9.0mn | 2025 |
| MLSS | MILESTONE SCIENTIFIC INC. | US | Pharmaceuticals & Healthcare | NYSE | $9.0mn | 2025 |
| BMGL | Basel Medical Group Ltd | SG | Pharmaceuticals & Healthcare | NASDAQ | SGD 11.3mn | 2025 |
| NUWE | Nuwellis, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $8.3mn | 2025 |
| ROIV | Roivant Sciences Ltd. | GB | Pharmaceuticals & Healthcare | NASDAQ | $8.3mn | 2026 |
| 4582 | シンバイオ製薬 | JP | Pharmaceuticals & Healthcare | Growth | ¥1bn | 2025 |
| COYA | Coya Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $7.9mn | 2025 |
| ACRS | Aclaris Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $7.8mn | 2025 |
| BOLT | Bolt Biotherapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $7.7mn | 2025 |
| XAIR | Beyond Air, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $7.7mn | 2026 |
| ADAG | Adagene Inc. | CN | Pharmaceuticals & Healthcare | NASDAQ | $7.7mn | 2025 |
| EVAX | Evaxion A/S | DK | Pharmaceuticals & Healthcare | NASDAQ | $7.5mn | 2025 |
| XENE | Xenon Pharmaceuticals Inc. | CA | Pharmaceuticals & Healthcare | NASDAQ | $7.5mn | 2025 |
| BGLC | BioNexus Gene Lab Corp | MY | Pharmaceuticals & Healthcare | NASDAQ | $7.4mn | 2025 |
| OVID | Ovid Therapeutics Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $7.3mn | 2025 |
| IMMP | IMMUTEP Ltd | AU | Pharmaceuticals & Healthcare | NASDAQ | AUD 10.3mn | 2025 |
| WHWK | Whitehawk Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $7.1mn | 2025 |
| IVF | INVO Fertility, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $6.8mn | 2025 |
| EUDA | EUDA Health Holdings Ltd | SG | Pharmaceuticals & Healthcare | NASDAQ | $6.8mn | 2025 |
| FATE | FATE THERAPEUTICS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $6.6mn | 2025 |
| KYNB | KYNTRA BIO, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $6.4mn | 2025 |
| 4570 | 免疫生物研究所 | JP | Pharmaceuticals & Healthcare | Growth | ¥1bn | 2026 |
| ABEO | ABEONA THERAPEUTICS INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $5.8mn | 2025 |
| DBVT | DBV Technologies S.A. | FR | Pharmaceuticals & Healthcare | NASDAQ | $5.6mn | 2025 |
| CNSY | CERENOME, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $5.2mn | 2025 |
| 4564 | オンコセラピー・サイエンス | JP | Pharmaceuticals & Healthcare | Growth | ¥809mn | 2026 |
| IMRN | Immuron Ltd | AU | Pharmaceuticals & Healthcare | NASDAQ | AUD 7.3mn | 2025 |
| ENSC | Ensysce Biosciences, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $5.1mn | 2025 |
| PMI | Picard Medical, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $4.9mn | 2025 |
| LUCD | Lucid Diagnostics Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $4.7mn | 2025 |
| PRME | Prime Medicine, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $4.6mn | 2025 |
| BMRA | BIOMERICA INC | US | Pharmaceuticals & Healthcare | NASDAQ | $4.5mn | 2026 |
| 4593 | ヘリオス | JP | Pharmaceuticals & Healthcare | Growth | ¥704mn | 2025 |
| OCGN | Ocugen, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $4.4mn | 2025 |
| ACIU | AC Immune SA | CH | Pharmaceuticals & Healthcare | NASDAQ | CHF 3.6mn | 2025 |
| 206A | ＰＲＩＳＭ ＢｉｏＬａｂ | JP | Pharmaceuticals & Healthcare | Growth | ¥677mn | 2025 |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $4.2mn | 2026 |
| CPHI | CHINA PHARMA HOLDINGS, INC. | CN | Pharmaceuticals & Healthcare | NYSE | $4.1mn | 2025 |
| IMDX | Insight Molecular Diagnostics Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $4.1mn | 2025 |
| CRVO | CervoMed Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $4.0mn | 2025 |
| TNON | Tenon Medical, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $3.9mn | 2025 |
| SLGL | Sol-Gel Technologies Ltd. | IL | Pharmaceuticals & Healthcare | NASDAQ | $3.8mn | 2025 |
| 4583 | カイオム・バイオサイエンス | JP | Pharmaceuticals & Healthcare | Growth | ¥593mn | 2025 |
| 4572 | カルナバイオサイエンス | JP | Pharmaceuticals & Healthcare | Growth | ¥579mn | 2025 |
| RADX | Radiopharm Theranostics Ltd | AU | Pharmaceuticals & Healthcare | NASDAQ | $3.6mn | 2025 |
| NRXS | Neuraxis, INC | US | Pharmaceuticals & Healthcare | NYSE | $3.6mn | 2025 |
| MRKR | Marker Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $3.5mn | 2025 |
| CRSP | CRISPR Therapeutics AG | CH | Pharmaceuticals & Healthcare | NASDAQ | $3.5mn | 2025 |
| CAMP | Camp4 Therapeutics Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $3.5mn | 2025 |
| SRZN | Surrozen, Inc./DE | US | Pharmaceuticals & Healthcare | NASDAQ | $3.5mn | 2025 |
| ICCM | IceCure Medical Ltd. | IL | Pharmaceuticals & Healthcare | NASDAQ | $3.4mn | 2025 |
| DYAI | DYADIC INTERNATIONAL INC | US | Pharmaceuticals & Healthcare | NASDAQ | $3.1mn | 2025 |
| TXMD | TherapeuticsMD, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $3.0mn | 2025 |
| XBIO | Xenetic Biosciences, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $3.0mn | 2025 |
| TRAW | Traws Pharma, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $2.8mn | 2025 |
| 4597 | ソレイジア・ファーマ | JP | Pharmaceuticals & Healthcare | Growth | ¥429mn | 2025 |
| MCTA | Charming Medical Ltd | HK | Pharmaceuticals & Healthcare | NASDAQ | $2.6mn | 2026 |
| GOVX | GeoVax Labs, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $2.5mn | 2025 |
| 4576 | デ・ウエスタン・セラピテクス研究所 | JP | Pharmaceuticals & Healthcare | Growth | ¥388mn | 2025 |
| CLGN | CollPlant Biotechnologies Ltd | IL | Pharmaceuticals & Healthcare | NASDAQ | $2.4mn | 2025 |
| FEMY | FEMASYS INC | US | Pharmaceuticals & Healthcare | NASDAQ | $2.3mn | 2025 |
| ALGS | Aligos Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $2.2mn | 2025 |
| 219A | Ｈｅａｒｔｓｅｅｄ | JP | Pharmaceuticals & Healthcare | Growth | ¥345mn | 2023 |
| 4888 | ステラファーマ | JP | Pharmaceuticals & Healthcare | Growth | ¥323mn | 2026 |
| HUMA | Humacyte, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $2.0mn | 2025 |
| NTRB | NutriBand Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $2.0mn | 2026 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | US | Pharmaceuticals & Healthcare | NASDAQ | $2.0mn | 2025 |
| ORMP | ORAMED PHARMACEUTICALS INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $2.0mn | 2025 |
| LPCN | Lipocine Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $2.0mn | 2025 |
| AVR | Anteris Technologies Global Corp. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.9mn | 2025 |
| VNRX | VOLITIONRX LTD | US | Pharmaceuticals & Healthcare | NYSE | $1.7mn | 2025 |
| RANI | Rani Therapeutics Holdings, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.6mn | 2025 |
| CLDX | Celldex Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.5mn | 2025 |
| ATPC | Agape ATP Corp | MY | Pharmaceuticals & Healthcare | NASDAQ | $1.5mn | 2025 |
| 4892 | サイフューズ | JP | Pharmaceuticals & Healthcare | Growth | ¥231mn | 2025 |
| OTLK | Outlook Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.4mn | 2025 |
| LFWD | Lifeward Ltd. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.4mn | 2025 |
| 4894 | クオリプス | JP | Pharmaceuticals & Healthcare | Growth | ¥212mn | 2026 |
| SCNI | Scinai Immunotherapeutics Ltd. | IL | Pharmaceuticals & Healthcare | NASDAQ | $1.3mn | 2025 |
| INBX | Inhibrx Biosciences, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.3mn | 2025 |
| VTGN | Vistagen Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.3mn | 2026 |
| 4890 | 坪田ラボ | JP | Pharmaceuticals & Healthcare | Growth | ¥200mn | 2026 |
| ICU | SeaStar Medical Holding Corp | US | Pharmaceuticals & Healthcare | NASDAQ | $1.2mn | 2025 |
| NRXP | NRX Pharmaceuticals, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.2mn | 2025 |
| LGVN | Longeveron Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.2mn | 2025 |
| BLRX | BioLineRx Ltd. | IL | Pharmaceuticals & Healthcare | NASDAQ | $1.2mn | 2025 |
| NEUP | Neuphoria Therapeutics Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.2mn | 2026 |
| SXTC | China SXT Pharmaceuticals, Inc. | CN | Pharmaceuticals & Healthcare | NASDAQ | $1.1mn | 2026 |
| RNXT | RenovoRx, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.1mn | 2025 |
| 4571 | ＮＡＮＯホールディングス | JP | Pharmaceuticals & Healthcare | Growth | ¥174mn | 2026 |
| DARE | Dare Bioscience, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.0mn | 2025 |
| SINT | Sintx Technologies, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.0mn | 2025 |
| PLUR | Pluri Inc. | IL | Pharmaceuticals & Healthcare | NASDAQ | $1.0mn | 2026 |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.0mn | 2025 |
| STTK | Shattuck Labs, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $1.0mn | 2025 |
| PROK | PROKIDNEY CORP. | US | Pharmaceuticals & Healthcare | NASDAQ | $893,000 | 2025 |
| RFL | Rafael Holdings, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $874,000 | 2026 |
| 4882 | ペルセウスプロテオミクス | JP | Pharmaceuticals & Healthcare | Growth | ¥136mn | 2026 |
| VJET | Flyte Aviation, Inc. | US | Pharmaceuticals & Healthcare | NYSE | $819,000 | 2025 |
| ONCO | Onconetix, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $815,371 | 2025 |
| 4586 | メドレックス | JP | Pharmaceuticals & Healthcare | Growth | ¥128mn | 2025 |
| IMA | ImageneBio, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $800,000 | 2025 |
| MCRB | Seres Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $789,000 | 2025 |
| LEXX | Lexaria Bioscience Corp. | CA | Pharmaceuticals & Healthcare | NASDAQ | $705,923 | 2025 |
| CODX | Co-Diagnostics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $622,489 | 2025 |
| YDES | YD Bio Ltd | TW | Pharmaceuticals & Healthcare | NASDAQ | $596,817 | 2025 |
| CRDF | Cardiff Oncology, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $593,000 | 2025 |
| ELAB | PMGC Holdings Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $590,084 | 2025 |
| SLN | Silence Therapeutics plc | GB | Pharmaceuticals & Healthcare | NASDAQ | $559,000 | 2025 |
| QUCY | Quantum Cyber N.V. | DE | Pharmaceuticals & Healthcare | NASDAQ | $537,080 | 2025 |
| ITOC | iTonic Holdings Ltd | CN | Pharmaceuticals & Healthcare | NASDAQ | $523,031 | 2025 |
| MREO | Mereo BioPharma Group plc | GB | Pharmaceuticals & Healthcare | NASDAQ | $500,000 | 2025 |
| MGRX | MANGOCEUTICALS, INC. | US | Pharmaceuticals & Healthcare | NASDAQ | $456,021 | 2025 |
| 4884 | クリングルファーマ | JP | Pharmaceuticals & Healthcare | Growth | ¥72mn | 2025 |
| XTLB | XTL BIOPHARMACEUTICALS LTD | US | Pharmaceuticals & Healthcare | NASDAQ | $451,000 | 2024 |
| SCNX | Scienture Holdings, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $431,609 | 2025 |
| MNOV | MEDICINOVA INC | US | Pharmaceuticals & Healthcare | NASDAQ | $409,657 | 2025 |
| CANF | Can-Fite BioPharma Ltd. | IL | Pharmaceuticals & Healthcare | NYSE | $405,000 | 2025 |
| RNAC | Cartesian Therapeutics, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $400,000 | 2025 |
| BRTX | BioRestorative Therapies, Inc. | US | Pharmaceuticals & Healthcare | NASDAQ | $359,700 | 2025 |